Trump’s Plan to Cap Drug Prices Doesn’t Exist

Donald Trump nearly proposed a significant healthcare policy to lower prescription drug costs by pegging them to other countries' prices, but instead of a concrete plan, he issued vague directives that risked harming Big Pharma. The administration's approach, focusing on threatening European nations with tariffs and cutting research funding, has failed to address the root cause—American patients are often subsidizing global health systems while Big Pharma benefits. More effective solutions exist, such as expanding federal negotiations or investing in drug innovation, which Trump has overlooked in favor of protectionist tactics that exacerbate the issue rather than solve it.